Alex D'souzaManaging Editoreditor@healthcaretechoutlook.comMolecular diagnostics was once a term recognizable only among the medical community. Even though the concept of molecular diagnostics (MDx) predates the COVID-19 pandemic by more than two decades, the adoption rate was quite low until recently. However, the COVID-19 pandemic opened the gates for new diagnostic procedures, thanks to the advent of RT-PCR tests.MDx plays a major role in the public health space by assessing the presence of disease causing strains in the DNA and delivering a more tailored cure to the individual's genetic profile. MDx offers an innovative approach to detecting chronic diseases in real-time while reducing the transmission risk for patients and healthcare workers. Next-generation sequencing (NGS) is an upcoming tool of MDx and is projected to grow at a CAGR of 12% through 2026. It is used to characterize cancer genomes resulting in the discovery of numerous genetic markers and opening up new avenues for research and cure. The increased demand for genetic and genomic information has led to the rapid expansion of molecular techniques within clinical laboratories. Diagnostic laboratories are also teaming up with pharmaceutical companies to formulate safer and more effective treatment, in turn helping the market escalate. However, the shift towards molecular diagnostics will call for trained professionals hailing from biomedical and laboratory science backgrounds and deploying new age instruments to cater to the market's growing demand at a reasonable cost. Consequently, healthcare experts are considering strengthening their capacity to support such a shift and improve their future stance. In this edition of Healthcare Tech Outlook, we bring you some of the prominent players in the molecular diagnostics market. This edition also includes exclusive insights from thought leaders for aspiring CIOs and CXOs. We hope this will assist you in opting for the right molecular diagnostics provider in Europe as per your requirements.Do write us your thoughts!An Effective Way to Achieve Precision MedicineEditorialManaging EditorAlex D'souzaEditorial StaffAaron PaulJoe PhillipJames SmithMark RobertVisualizerUTLOOKHealthcare Tech Copyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEmail:sales@healthcaretechoutlook.comeditor@healthcaretechoutlook.commarketing@healthcaretechoutlook.comImmanuelJohn GothamSalesRich Gonsalves rich@healthcaretechoutlook.comNovember - 22 - 2021, volume 07 - Issue 17 Published by ValleyMedia, Inc. (ISSN 2691 - 3933)To subscribe to HealthcareTech OutlookVisit www.healthcaretechoutlook.com UTLOOKHealthcare Tech
< Page 5 | Page 7 >